Roberto Santambrogio

Dr. Roberto Santambrogio

US CHIRURGIA EPATO-BILIARE, Azienda Ospedaliera Fatebenefratelli e Oftalmico, Milan, Lombardy, Italy
orcid

Research Focus & Metrics

Academic Career Length

44Years (1983-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2013 in HPB
Verified
Journal Article
Open access
PDF file
RSRoberto Santambrogio
Roberto Santambrogio
MKMichael Kluger
Michael Kluger
MCMara Costa
Mara Costa
ABAndrea Belli
Andrea Belli
MBMatteo Barabino
Matteo Barabino
DCDaniel Cherqui
Daniel Cherqui
In 1996, the Barcelona group demonstrated the presence of clinically significant portal hypertension (PHTN), defined as a hepatic venous pressure gradient (HVPG) ≥ 10 mmHg, to be the most powerful predictor of post‐operative liver decompensation and, in a subsequent (1999) publication, of poor long‐term outcome in Child–Pugh A cirrhotic patients submitted to hepatic resection (HR).1. x 1. Bruix, J., Castells, A., Bosch, J., Feu, F., Fuster, J., and Garcia‐Pagan, J.C. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology. 1996; 111: 1018–1022 Abstract | Full Text PDF | PubMed | Scopus (605) | Google Scholar See all References , 2. x 2. Llovet, J.M., Fuster, J., and Bruix, J. Intention‐to‐treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology. 1999; 30: 1434–1440 Crossref | PubMed | Scopus (1283) | Google Scholar See all References However, measurement of HVPG is invasive and requires technical expertise, whereas other clinical parameters are more easily evaluated.3 x 3. De Franchis, R., Dell'Era, A., and Primignani, M. Diagnosis and monitoring of portal hypertension. Dig Liver Dis. 2008; 40: 312–317 Abstract | Full Text | Full Text PDF | PubMed | Scopus (38) | Google Scholar See all References Indeed, the presence of oesophageal varices as determined by endoscopy or significant splenomegaly (major diameter >12 cm) with a platelet count of <100 000/mm3 are considered surrogate markers of clinically significant PHTN, regardless of portal pressure measurements.4 x 4. Bruix, J. and Sherman, M. Management of hepatocellular carcinoma. Hepatology. 2005; 42: 1208–1236 Crossref | PubMed | Scopus (4202) | Google Scholar See all References As a consequence of these studies, the European Association for the Study of the Liver (EASL) and American Association for the Study of Liver Diseases (AASLD) guidelines consider PHTN to be a relative contraindication to HR because of the high risk of post‐operative liver decompensation.4. x 4. Bruix, J. and Sherman, M. Management of hepatocellular carcinoma. Hepatology. 2005; 42: 1208–1236 Crossref | PubMed | Scopus (4202) | Google Scholar See all References , 5. x 5. Bruix, J. and Sherman, M. Management of hepatocellular carcinoma: an update. Hepatology. 2011; 53: 1020–1022 Crossref | PubMed | Scopus (4320) | Google Scholar See all References

27 April 2009 in BMC Cancer
Verified
Journal Article
Open access
PDF file
CAClaudia Augello
Claudia Augello
LCLuca Caruso
Luca Caruso
MMMarco Maggioni
Marco Maggioni
MDMatteo Donadon
Matteo Donadon
MMMarco Montorsi
Marco Montorsi
SBSilvano Bosari
Silvano Bosari
Background: Similarly to other tumor types, an imbalance between unrestrained cell proliferation and impaired apoptosis appears to be a major unfavorable feature of hepatocellular carcinoma (HCC). The members of IAP family are key regulators of apoptosis, cytokinesis and signal transduction. IAP survival action is antagonized by specific binding of Smac/DIABLO and XAF1. This study aimed to investigate the gene and protein expression pattern of IAP family members and their antagonists in a series of human HCCs and to assess their clinical significance. Methods: Relative quantification of IAPs and their antagonist genes was assessed by quantitative Real Time RT-PCR (qPCR) in 80 patients who underwent surgical resection for HCC. The expression ratios of XIAP/XAF1 and of XIAP/Smac were also evaluated. Survivin, XIAP and XAF1 protein expression were investigated by immunohistochemistry. Correlations between mRNA levels, protein expression and clinicopathological features were assessed. Follow-up data were available for 69 HCC patients. The overall survival analysis was estimated according to the Kaplan-Meier method. Results: Survivin and Livin/ML-IAP mRNAs were significantly over-expressed in cancer tissues compared to non-neoplastic counterparts. Although Survivin immunoreactivity did not correlate with qPCR data, a significant relation was found between higher Survivin mRNA level and tumor stage, tumor grade and vascular invasion. The mRNA ratio XIAP/XAF1 was significantly higher in HCCs than in cirrhotic tissues. Moreover, high XIAP/XAF1 ratio was an indicator of poor prognosis when overall survival was estimated and elevated XIAP immunoreactivity was significantly associated with shorter survival. Conclusion: Our study demonstrates that alterations in the expression of IAP family members, including Survivin and Livin/ML-IAP, are frequent in HCCs. Of interest, we could determine that an imbalance in XIAP/XAF1 mRNA expression levels correlated to overall patient survival, and that high XIAP immunoreactivity was a poor prognostic factor.

1 July 1999 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
RSRoberto Santambrogio
Roberto Santambrogio
MMMarco Montorsi
Marco Montorsi
PBPaolo Bianchi
Paolo Bianchi
AMAngelo Mantovani
Angelo Mantovani
FGFilippo Ghelma
Filippo Ghelma
MMMaurizio Mezzetti
Maurizio Mezzetti

1 January 1994 in Journal of Hepatology
Verified
Journal Article
Closed access
GSGian Paulo Spina
Gian Paulo Spina
RARaffaele Arcidiacono
Raffaele Arcidiacono
JBJaime Bosch
Jaime Bosch
LPLuigi Pagliaro
Luigi Pagliaro
ABAndrew K. Burroughs
Andrew K. Burroughs
ARAlfredo Rossi
Alfredo Rossi

1 January 2005 in Journal of Gastrointestinal Surgery
Verified
Journal Article
Closed access
MMMarco Montorsi
Marco Montorsi
RSRoberto Santambrogio
Roberto Santambrogio
PBPaolo Bianchi
Paolo Bianchi
MDMatteo Donadon
Matteo Donadon
EMEliana Moroni
Eliana Moroni
MCMara Costa
Mara Costa

19 March 2012 in Liver International
Verified
Journal Article
Closed access
PDF file
CAClaudia Augello
Claudia Augello
VVValentina Vaira
Valentina Vaira
LCLuca Caruso
Luca Caruso
ADAnnarita Destro
Annarita Destro
MMMarco Maggioni
Marco Maggioni
SBSilvano Bosari
Silvano Bosari